Last week we reported that the FDA advisory board had given their blessing to the new long-acting insulin, degludec. However, trying to find good information about this product, how it works, and what makes it different from insulin glargine or insulin detimir, has been next to impossible. This week, our PharmD candidate, Andre McMahon, has put together a set of Homerun Slides that you can use to explain this new insulin to your collegues.
Our Clinical Text discusses how Joslin looks at carb counting, while this week’s Mastery In Minutes video helps out with some advice from Dr. Martha Funnell on exactly how to get those patients counting, and the Disaster Averted gives a good example of why pens are not as simple as you would think to teach.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.